Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Alkermes Has Increased The Buyout For Avadel Pharmaceuticals To Up To $22.50 Per Share, Consisting Of $21.00 In Cash And 1 Contingent Value Right Of Additional Cash Payment Of $1.50 Per Share

Author: Benzinga Newsdesk | November 19, 2025 06:02am

Posted In: ALKS AVDL